Stratified therapy for Kawasaki disease using a new scoring system to predict the response to a lower dose of intravenous immunoglobulin therapy

Revision of diagnostic guidelines for Kawasaki disease (6th revised edition)

(2020) Tohru Kobayashi et al.   PEDIATRICS INTERNATIONAL

Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial

(2019) Hiromichi Hamada et al.   LANCET

A New Z Score Curve of the Coronary Arterial Internal Diameter Using the Lambda-Mu-Sigma Method in a Pediatric Population

(2016) Tohru Kobayashi et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

(2012) Y Kanda   BONE MARROW TRANSPLANTATION

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial

(2012) Tohru Kobayashi et al.   LANCET

Corticosteroid Pulse Combination Therapy for Refractory Kawasaki Disease: A Randomized Trial

(2011) S. Ogata et al.   PEDIATRICS

Prediction of responsiveness or non-responsiveness to treatment of acute Kawasaki disease using 1 gram per kilogram of immunoglobulin – an effective and cost-saving schedule of therapy

(2009) Ko Ichihashi et al.   CARDIOLOGY IN THE YOUNG

Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease

(2008) Keiko Okada et al.   EUROPEAN JOURNAL OF PEDIATRICS

Intravenous immunoglobulin: Adverse reactions and management

(2008) Francisco A. Bonilla   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY